BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 2430188)

  • 1. Tumour necrosis factors alpha and beta inhibit virus replication and synergize with interferons.
    Wong GH; Goeddel DV
    Nature; 1986 Oct 30-Nov 5; 323(6091):819-22. PubMed ID: 2430188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human cytokines, tumor necrosis factor, and interferons: gene cloning, animal studies, and clinical trials.
    Bollon AP; Berent SL; Torczynski RM; Hill NO; Lemeshev Y; Hill JM; Jia FL; Joher A; Pichyangkul S; Khan A
    J Cell Biochem; 1988 Apr; 36(4):353-67. PubMed ID: 2454238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of innate immunity against herpes simplex virus type 2 infection via local delivery of Toll-like receptor ligands correlates with beta interferon production.
    Gill N; Deacon PM; Lichty B; Mossman KL; Ashkar AA
    J Virol; 2006 Oct; 80(20):9943-50. PubMed ID: 17005672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral effects of recombinant human tumor necrosis factor.
    Ito M; O'Malley JA
    Lymphokine Res; 1987; 6(4):309-18. PubMed ID: 2448553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous production of tumor necrosis factor in normal mice and human cancer patients by interferons and other cytokines combined with biological response modifiers of bacterial origin.
    Satoh M; Inagawa H; Shimada Y; Soma G; Oshima H; Mizuno D
    J Biol Response Mod; 1987 Oct; 6(5):512-24. PubMed ID: 2445926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor enhances HLA-A,B,C and HLA-DR gene expression in human tumor cells.
    Pfizenmaier K; Scheurich P; Schlüter C; Krönke M
    J Immunol; 1987 Feb; 138(3):975-80. PubMed ID: 2433337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms for the inhibition of HIV replication by interferons-alpha, -beta, and -gamma in primary human macrophages.
    Meylan PR; Guatelli JC; Munis JR; Richman DD; Kornbluth RS
    Virology; 1993 Mar; 193(1):138-48. PubMed ID: 7679856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individual differentiation of innate antiviral immunity in humans; the role of endogenous interferons and tumor necrosis factor in the immunity of leukocytes.
    Orzechowska B; Antoszków Z; Błach-Olszewska Z
    Arch Immunol Ther Exp (Warsz); 2003; 51(1):51-60. PubMed ID: 12691304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monocyte-derived human macrophages and peripheral blood mononuclear cells infected with ebola virus secrete MIP-1alpha and TNF-alpha and inhibit poly-IC-induced IFN-alpha in vitro.
    Gupta M; Mahanty S; Ahmed R; Rollin PE
    Virology; 2001 May; 284(1):20-5. PubMed ID: 11352664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antiviral activity of tumor necrosis factor in HeLa cells is not mediated by interferons. Studies with TNF-resistant variants.
    Gessani S; Johnson SE; McCandless S; Baglioni C
    J Biol Regul Homeost Agents; 1988; 2(3):139-44. PubMed ID: 2474237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colony inhibitory effect of recombinant human tumor necrosis factor (rH-TNF) and/or recombinant human interferon (rH-IFN)-alpha, -beta and -gamma on human lung cancer cell lines.
    Hong WS; Jett JR; Sasaki Y; Takahashi H; Nakano H; Nakagawa K; Hoshi A; Saijo N
    Jpn J Clin Oncol; 1987 Mar; 17(1):49-55. PubMed ID: 2435930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage control of herpes simplex virus type 1 replication in the peripheral nervous system.
    Kodukula P; Liu T; Rooijen NV; Jager MJ; Hendricks RL
    J Immunol; 1999 Mar; 162(5):2895-905. PubMed ID: 10072539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of antiviral activity of spotted souslik (Spermophilus suslicus) interferons.
    Kandefer-Szerszeń M
    Arch Immunol Ther Exp (Warsz); 1987; 35(4):489-99. PubMed ID: 2449874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of tumor necrosis factor and interferon triggered responses by DNA viruses.
    Krajcsi P; Wold WS
    Semin Cell Dev Biol; 1998 Jun; 9(3):351-8. PubMed ID: 9665872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural killer-sensitive targets stimulate production of TNF-alpha but not TNF-beta (lymphotoxin) by highly purified human peripheral blood large granular lymphocytes.
    Peters PM; Ortaldo JR; Shalaby MR; Svedersky LP; Nedwin GE; Bringman TS; Hass PE; Aggarwal BB; Herberman RB; Goeddel DV
    J Immunol; 1986 Oct; 137(8):2592-8. PubMed ID: 3760569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signaling through the lymphotoxin-beta receptor stimulates HIV-1 replication alone and in cooperation with soluble or membrane-bound TNF-alpha.
    Marshall WL; Brinkman BM; Ambrose CM; Pesavento PA; Uglialoro AM; Teng E; Finberg RW; Browning JL; Goldfeld AE
    J Immunol; 1999 May; 162(10):6016-23. PubMed ID: 10229841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of growth factors on the antiproliferative activity of tumor necrosis factors.
    Sugarman BJ; Lewis GD; Eessalu TE; Aggarwal BB; Shepard HM
    Cancer Res; 1987 Feb; 47(3):780-6. PubMed ID: 3802082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bryostatin-1 and IFN-gamma synergize for the expression of the inducible nitric oxide synthase gene and for nitric oxide production in murine macrophages.
    Taylor LS; Cox GW; Melillo G; Bosco MC; Espinoza-Delgado I
    Cancer Res; 1997 Jun; 57(12):2468-73. PubMed ID: 9192827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral potential of interferon-omega on hepatitis B virus replication in human hepatoma cells.
    Hagelstein J; Kist A; Stremmel W; Galle PR
    Arzneimittelforschung; 1998 Mar; 48(3):343-7. PubMed ID: 9553691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disparate effects of tumor necrosis factor-alpha/cachectin and tumor necrosis factor-beta/lymphotoxin on hematopoietic growth factor production and neutrophil adhesion molecule expression by cultured human endothelial cells.
    Broudy VC; Harlan JM; Adamson JW
    J Immunol; 1987 Jun; 138(12):4298-302. PubMed ID: 3495589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.